Migraine is a continually evolving field and may challenge clinicians with continually updated guidelines and consensus statements. This interactive, case-based activity will provide a comprehensive review of migraine prevalence and strategies to improve diagnosis. This education will also address health disparities and access to care in different population of patients with migraine, the role of calcitonin gene-related peptide (CGRP) in migraine pathophysiology, and the mechanism of action (MOA), efficacy, safety, and clinical applications of CGRPs to assist PAs in making informed treatment choices tailored to individual patients while promoting equitable care for all patients with migraine.

Learning Objectives

---

At the conclusion of this activity, participants should be able to:

• Explain the prevalence, burden, and impact of migraine in different patient populations
• Review the diagnostic criteria for migraine and its differential diagnosis from other headache disorders
• Describe the role of CGRP in migraine pathophysiology
• Compare and contrast clinical profiles of acute and preventative migraine treatments

Acknowledgement of Commercial Support

---

This activity is supported by an educational grant from Pfizer.